ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW IN I AND II:I. A RANDOMIZED BLINDED CONTROLLED TRIAL OF TH
$13,721,004N01FY2024AINIH
Leidos Biomedical Research, Inc., Frederick MD
Leidos Biomedical Research, Inc., Frederick MD